Related Experiment Video
Updated: Jul 7, 2026
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
Treatment of a juxtaglomerular tumour with radiofrequency ablation
Alexander P S Kirkham1, Stephen G F Ho, Ryan F Paterson
1Department of Radiology, Vancouver General Hospital, Vancouver, British Columbia, Canada. alexkirkham@yahoo.com
Abstract:
Juxtaglomerular tumors, or reninomas, are a rare cause of hypertension, almost always benign and accurately localized by a combination of biochemical tests and imaging. Because the tumors are usually small at presentation, and there are good markers for recurrence, we consider treatment by radiofrequency ablation a useful alternative to nephron-sparing surgery and describe its use in one patient.
Insights
Juxtaglomerular tumors (reninomas) are rare causes of hypertension. Radiofrequency ablation offers a minimally invasive alternative to surgery for these small, typically benign tumors.
Area of Science:
- Nephrology
- Oncology
- Endocrinology
Background:
- Juxtaglomerular tumors, also known as reninomas, are rare neoplasms.
- They are a significant, albeit uncommon, cause of secondary hypertension.
- These tumors are often associated with elevated renin levels.
Observation:
- Reninomas are typically small at the time of diagnosis.
- They are almost always benign.
- Accurate localization is achievable through biochemical assays and advanced imaging techniques.
Findings:
- Radiofrequency ablation (RFA) is presented as a viable treatment option.
- RFA is considered a useful alternative to nephron-sparing surgery.
- The study details the successful application of RFA in a single patient case.
Implications:
- Radiofrequency ablation provides a less invasive therapeutic approach for reninomas.
- This minimally invasive technique may reduce patient morbidity compared to traditional surgery.
- Further research into RFA for reninomas could expand minimally invasive treatment options for endocrine hypertension.
